东材科技公告称，公司于2025年8月7日通过变更回购股份用途并注销暨减资议案，拟将已回购未使用的 793.49万股股份用途由"实施股权激励"变更为"注销并减资"。回购股份注销后，总股本将由10.18亿股减 至10.10亿股，注册资本由1.02亿元减至1.01亿元。根据规定，自公告披露日起45日内，债权人可要求公 司偿债或提供担保，可按指定方式申报债权，联系人陈杰，电话028 - 65498663。 ...

Core Points - Jiangzhong Pharmaceutical Co., Ltd. announced a cash dividend of 0.5 yuan per share for the first half of 2025, approved at the temporary shareholders' meeting on September 8, 2025 [1][3]. Distribution Plan - The total cash dividend distribution amounts to 317,498,011 yuan based on a total share capital of 634,996,022 shares [3]. - The distribution is applicable to all shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the day before the equity registration [2]. Implementation Details - The cash dividends will be distributed through the clearing system of China Securities Depository and Clearing Corporation Limited, with shareholders who have designated trading able to receive their dividends on the payment date [4]. - For shareholders who have not designated trading, the dividends will be held by China Securities Depository and Clearing Corporation Limited until they complete the designation [4]. Taxation Information - Individual shareholders holding shares for over one year are exempt from personal income tax on dividends, while those holding for less than one year will have tax deducted upon transfer of shares [7][8]. - For qualified foreign institutional investors (QFII), a 10% withholding tax will apply, resulting in a net dividend of 0.45 yuan per share [9]. Recent Board Decisions - The board approved the acquisition of 70% of Jingcheng Huyao's shares for no more than 70.78393 million yuan to enhance the company's OTC product matrix [13]. - The board also approved the initiation of the second phase of the Smart Decoction Center project with an estimated investment of 11.15 million yuan to expand production capacity [14]. - A decision was made to reduce investment in Sanghai Pharmaceutical by transferring 51.0044% of its shares, with a capital reduction of 39 million yuan [15]. - The board agreed to adjust the disposal plan for the Sangji Project Company, opting for an absorption merger instead of a public transfer [17].

Core Viewpoint - Maanshan Iron & Steel Co., Ltd. (00323) has signed a capital reduction agreement with Baowu Water and eighteen other shareholders, aiming to enhance operational efficiency and effectiveness through a reduction of RMB 538 million [1] Group 1: Capital Reduction Details - The capital reduction involves three shareholders, including Maanshan Iron & Steel, while the other sixteen shareholders will not participate in the reduction [1] - Maanshan Iron & Steel's equity stake in Baowu Water will decrease from 14.977% to 3.151% following the capital reduction [1] Group 2: Operational Impact - The capital reduction is intended to improve Maanshan Iron & Steel's operational efficiency and will not significantly impact its daily operations and financial status [1] - By acquiring the circulating water assets related to its production, Maanshan Iron & Steel aims to lower operational costs and enhance production stability and synergy [1]

Core Viewpoint - Maanshan Iron & Steel Co., Ltd. (00323) has signed a capital reduction agreement with Baowu Water and eighteen other shareholders, reducing its stake in Baowu Water from 14.977% to 3.151% through a capital reduction of RMB 538 million [1] Group 1: Capital Reduction Details - The capital reduction involves three shareholders, including Maanshan Iron & Steel, while the other sixteen shareholders will not participate in the reduction [1] - The capital reduction is aimed at enhancing the operational efficiency and effectiveness of Maanshan Iron & Steel [1] Group 2: Impact on Operations - The capital reduction will not significantly impact the daily operations and financial status of Maanshan Iron & Steel [1] - By retaining water assets closely related to its production, Maanshan Iron & Steel aims to lower operational costs and improve production stability [1]

Core Viewpoint - Tianjin Zhonglv Electric Investment Co., Ltd. has announced a share repurchase plan aimed at canceling shares and reducing registered capital, along with notifying creditors about the implications of this action [1][2]. Group 1: Share Repurchase Plan - The company will use self-raised funds to repurchase shares through centralized bidding, with a total fund amounting to no less than 61.84 million yuan and no more than 92.76 million yuan, at a maximum price of 13.31 yuan per share [2]. - The implementation period for the share repurchase is set for 12 months from the date of approval at the third extraordinary shareholders' meeting in September 2025 [2]. Group 2: Creditor Notification - Following the cancellation of repurchased shares, the company's registered capital will decrease, prompting the company to notify creditors that they have 45 days from the announcement date (September 17, 2025) to claim debts or request guarantees [3]. - Creditors must provide original and photocopied documents proving the existence of the debt relationship, and specific requirements vary for corporate and individual creditors [3].

Group 1 - The company, Shenzhen Baiwei Storage Technology Co., Ltd., has announced a share repurchase plan through centralized bidding, intending to buy back shares worth no less than 20 million yuan and no more than 40 million yuan using its own or raised funds [1] - The repurchase price will not exceed 97.90 yuan per share, and the duration of the buyback will be 12 months from the date of approval by the shareholders' meeting [1] - Some directors, senior executives, and shareholders holding more than 5% of the shares have not completed their reduction plans and will continue to reduce their holdings as originally planned [1]

Core Viewpoint - The company, Tianjin Lianlong New Materials Co., Ltd., has approved a merger between its subsidiaries, Tianjin Aoruifei Biopharmaceutical Co., Ltd. and Tianjin Aolife Biotechnology Co., Ltd., to optimize resource allocation and improve management efficiency [1][9]. Summary by Sections 1. Overview of Related Transactions - The merger will involve Aoruifei absorbing Aolife, leading to Aolife's termination and cancellation of its legal status. Aoruifei will inherit all assets, liabilities, and rights from Aolife, and its registered capital will be reduced from 1.5 billion to 1.282 billion yuan [1][7]. 2. Basic Information of Related Parties - Tianjin Jukanglong Enterprise Management Partnership (Limited Partnership) holds a 30% stake in Aoruifei. The partnership is formed by the company's directors and senior management [2][4]. 3. Basic Information of the Merged Entities - Aolife has a registered capital of 5 million yuan and focuses on biochemistry product R&D and manufacturing. Aoruifei has a registered capital of 10 million yuan and engages in medical research and specialized chemical product sales [4][6]. 4. Arrangements for Merger and Capital Reduction - After the merger, Aoruifei will reduce its registered capital by 218 million yuan, and all assets and liabilities of Aolife will be transferred to Aoruifei [7][8]. 5. Pricing Policy and Basis for the Transaction - The pricing for the merger is based on the profitability and net asset scale of Aoruifei and Aolife, ensuring fairness and reasonableness in the transaction [9][11]. 6. Impact and Purpose of the Merger - The merger aims to optimize resource allocation, enhance management efficiency, and reduce management costs, with no substantial impact on the company's operations or shareholder interests [9][10]. 7. Board and Independent Director Review - The independent directors and the board's audit committee have reviewed and approved the merger, concluding it benefits the company and does not harm shareholder interests [10][11].

Core Viewpoint - Aurora Optoelectronics Co., Ltd. plans to repurchase and cancel a total of 12,065,449 performance compensation shares from specific investors, completing their performance compensation obligations [1][3]. Group 1: Repurchase and Cancellation Details - The company will repurchase shares from several performance compensation obligors at a total price of RMB 1.00, and the repurchased shares will be canceled in batches according to the actual progress [3]. - The repurchased shares represent 0.44% of the company's total share capital before the repurchase [3]. Group 2: Performance Compensation Obligors - Performance compensation obligors Zuo Hongbo and Chu Shuxia are required to compensate a total of 390,706,608 shares, but they currently hold 235,423,715 shares, all of which are subject to judicial freezing [2]. - The company faces significant uncertainty in pursuing compensation from Zuo Hongbo and Chu Shuxia due to their personal asset rights being restricted by other debt disputes [2]. Group 3: Notification to Creditors - The company has notified creditors about the repurchase and cancellation of shares, allowing them 30 days from notification or 45 days from the announcement date to claim debts or request guarantees [3][4]. - Creditors must submit written requests along with relevant proof of debt relationships to the company [4].

Group 1 - The company held its 23rd meeting of the second board of directors and the 20th meeting of the second supervisory board on April 18, 2025, and will hold the 2024 annual shareholders' meeting on May 13, 2025, to review and approve changes to the repurchase of shares and other related proposals [1] - The company decided to change the purpose of 1,804,360 shares (equivalent to 1.80436 million shares) from "for employee stock ownership plan or equity incentive" to "for cancellation and reduction of registered capital" [1] - The company will notify creditors about the reduction in total share capital and registered capital, allowing them to request debt repayment or provide corresponding guarantees within 45 days from the announcement date of May 21, 2025 [1] Group 2 - Creditors can submit their claims either in person or by mail, with specific requirements for documentation including original and photocopied contracts or agreements proving the existence of the debt relationship [2] - The claim submission period is from May 21, 2025, for 45 days, during working hours [2] - The submission location is Jiangsu Yangdian Technology Co., Ltd., located at 690 Tianmu Road, Jiangyan Economic Development Zone, Taizhou, Jiangsu, with a contact number provided for inquiries [2]

Core Viewpoint - Beijing Andawell Technology Co., Ltd. has announced the repurchase and cancellation of certain restricted stocks, which will lead to a reduction in registered capital and total share capital [2][3]. Group 1: Stock Repurchase and Cancellation - The company will repurchase and cancel a total of 469,300 shares of restricted stock held by 79 incentive recipients, including those who have left the company [2]. - The repurchase includes 70,000 shares from former employees and 399,300 shares due to unmet performance targets as per the incentive plan [2]. - Following the cancellation, the total share capital will decrease from 254,696,450 shares to 254,227,150 shares, and registered capital will reduce from 254,696,450 yuan to 254,227,150 yuan [2]. Group 2: Notification to Creditors - The company is notifying creditors about the capital reduction, allowing them 45 days from the announcement date to request debt repayment or guarantees [3]. - Creditors must submit written requests along with relevant documentation to the company within the specified period [3]. Group 3: Creditor Claim Submission Requirements - Creditors must provide original and copies of contracts or agreements proving the existence of the debt relationship when submitting claims [4]. - For corporate creditors, additional documents such as a business license and identification of the legal representative are required [4]. - Claims can be submitted through various methods including in-person, mail, email, or fax, with specific contact details provided for submissions [4][5].